By studying the expression and functional effects of F13B in HCC and endothelial cells, we seek to gain insight into its potential as a therapeutic target and prognostic marker, ultimately helping to improve patient outcomes and deepen our understanding of HCC pathogenesis. Here, F13B is linked to hepatocellular carcinoma.